#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cerebellar ataxia Anti-glomerular basement membrane disease Arrhythmogenic right ventricular dysplasia Acquired ATTR amyloidosis Hereditary spastic paraplegia Epstein-Barr virus infection Brain stem glioma Transplant rejection Follicular lymphoma Myxofibrosarcoma Cervix carcinoma recurrent Oesophageal adenocarcinoma stage II Oesophageal adenocarcinoma stage III Granulomatosis with polyangiitis Breast cancer More trials…

    Learn about Rare Diseases

    Mastocytosis – Diagnostics Mitochondrial myopathy – Diagnostics Congenital hypotransferrinaemia – Diagnostics Vascular malformation Ewing’s sarcoma metastatic Thrombotic thrombocytopenic purpura – Treatment Leukoencephalopathy – Trials in Disease Tuberous sclerosis complex Sarcoma – Life with Disease Paroxysmal nocturnal haemoglobinuria – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Avacincaptad Pegol Corifollitropin Alfa Zinc Oxide Metoprolol Succinate Desogestrel Furosemide Ph. Eur. AGANIRSEN Ibrutinib Abrocitinib Salbutamol Caspofungin Bicalutamide Pralatrexate Morf-057 Icatibant Calcium Chloride Co-Trimoxazole Pyrazinamide Ciclosporin Citric Acid Monohydrate More therapies…

    Learn about Your Condition

    Rectal cancer stage II Left ventricular failure Neurotrophic keratopathy Genitourinary tract neoplasm Tuberous sclerosis complex Clinically isolated syndrome Bronchostenosis Pemphigoid Adenocarcinoma gastric Viral myocarditis Metastases to liver Vaginal haemorrhage Stress urinary incontinence Peptostreptococcus infection Cystic fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Immune system processes

  • Study on Mavorixafor for Treating WHIM Syndrome in Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Immunodeficiency congenital
    Investigated Drugs:
    • Mavorixafor
    Denmark France Italy The Netherlands Spain

  • Study of RLS-0071 Treatment for Hospitalized Patients with Steroid-Resistant Acute Graft-versus-Host Disease (aGvHD)

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Acute graft versus host disease
    Investigated Drugs:
    • Ile-Ala-Leu-Ile-Leu-Glu-Pro-Ile-Cys-Cys-Gln-Glu-Arg-Ala-Ala-(Discrete-Polyethylene Glycol)24
    Germany Spain

  • Study on the Effects of Hyperbaric Oxygen Therapy for Patients with Moderate-to-Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Study on Siplizumab and Rabbit Anti-Thymocyte Globulin for Preventing Rejection in New Kidney Transplant Patients

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Rabbit Anti-Human Thymocyte Immunoglobulin
    • Siplizumab
    • Cetirizine Dihydrochloride
    Austria Spain Sweden

  • Study of Tocilizumab Treatment for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Kidney transplant rejection
    • Renal transplant
    Investigated Drugs:
    • Tocilizumab
    Spain Sweden

  • Study of Belimumab for Children with Systemic Lupus Erythematosus (SLE)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Belimumab
    Germany Spain
Previous Page
1 … 9 10 11 12 13 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!